Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MANÜ Telehealth vs Mint Med

By GLP-1 ScorecardUpdated

MANÜ Telehealth
Site position #93

Lower grade

Mint Med
Site position #45

Higher grade

Score comparison

Mint Med has the higher recorded score — 78.7/100 to 72.2/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueMint Med +5
85
90
Dose & formulationMint Med +16
64
80
Clinical oversightMANÜ Telehealth +24
79
55
Labs & monitoringMint Med +20
63
83
FulfillmentMint Med +11
71
82
Contract termsMint Med +31
55
86
MANÜ Telehealth · top barMint Med · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMANÜ TelehealthMint Med
WeighScore72.2/10078.7/100
GradeCC+
Site position#93#45
Semaglutide$120/mo (compounded)$117/mo
Tirzepatide$150/mo (compounded)$159/mo
CoverageCoverage not published36 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
MANÜ Telehealth

Site position #93 · C

Strengths

  • Compounded GLP-1s advertised from about $4-$5/day
  • 100% online with free discreet shipping and no insurance needed
  • Compounds exclusively from US 503A pharmacies
  • Add-on options like MIC Ultraburn and NAD+

What to consider

  • Per-dose pricing is gated behind login/signup, not public
  • State availability changes and is only confirmed at signup
  • Compounded medications are not FDA-evaluated
Mint Med

Site position #45 · C+

FDAWarning letter issued to Glow Medispa, LLC dba Mint Med in June 2026. See the FDA warning-letter database.

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

What to consider

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard